UVB Therapy for Pigmentary Disorders

The Pigmentary System: Physiology and Pathophysiology: Second Edition

Volumn , Issue , 2007, Pages 1183-1187

  Passeron, Thierry ^a   Ortonne, Jean Paul ^b  

^a University of Nice Sophia Antipolis ^*

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Dermatology; Electromagnetic waves; Photosensitization; Pigmentary disorders; Vitiligo

Indexed keywords

EID: 84889630360     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987100.ch61     Document Type: Chapter

References (55)

1. Akaraphanth, R., M. C. Douglass, and H. W. Lim. Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients. J. Am. Acad. Dermatol. 42(1 pt 1):33-39, 2000.
2. Anke Hartmann, C. L., H. Hamm, E.-B. Bröcker, and U. B. Hofmann. Narrow-band UVB311nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int. J. Dermatol. 44: 736-742, 2005.
3. Baltas, E., Z. Csoma, F. Ignacz, A. Dobozy, and L. Kemeny. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch. Dermatol. 138: 1619-1620, 2002.
4. Baltas, E., P. Nagy, B. Bonis, Z. Novak, F. Ignacz, G. Szabo, Z. Bor, A. Dobozy, and L. Kemeny. Repigmentation of localized vitiligo with the xenon chloride laser. Br. J. Dermatol. 144: 1266-1267, 2001.
5. Baysal, V., M. Yildirim, A. Erel, and D. Kesici. Is the combination of calcipotriol and PUVA effective in vitiligo? J. Eur. Acad. Dermatol. Venereol. 17: 299-302, 2003.
6. Castanedo-Cazares, J. P., V. Lepe, and B. Moncada. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band. Photodermatol. Photoimmunol. Photomed. 19: 35-36, 2003.
7. Chakraborty, A. K., Y. Funasaka, A. Slominski, J. Bolognia, S. Sodi, M. Ichihashi, and J. M. Pawelek. UV light and MSH receptors. Ann. N. Y. Acad. Sci. 885: 100-116, 1999.
8. Danno, K., K. Toda, and T. Horio. Ultraviolet-B radiation suppresses mast cell degranulation induced by compound 48/80. J. Invest. Dermatol. 87: 775-778, 1986.
9. Eller, M. S., and B. A. Gilchrest. Tanning as part of the eukaryotic SOS response. Pigment Cell Res. 13(Suppl 8):94-97, 2000.
10. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 151: 2390-2398, 1993.
11. Ermis, O., E. Alpsoy, L. Cetin, and E. Yilmaz. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br. J. Dermatol. 145: 472-475, 2001.
12. Esposito, M., R. Soda, A. Costanzo, and S. Chimenti. Treatment of vitiligo with the 308 nm excimer laser. Clin. Exp. Dermatol. 29: 133-137, 2004.
13. Friedman, P. M., and R. G. Geronemus. Use of the 308-nm excimer laser for postresurfacing leukoderma. Arch. Dermatol. 137: 824-825, 2001.
14. Garland, C. F., F. C. Garland, and E. D. Gorham. Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann. Epidemiol. 13: 395-404, 2003.
15. Gathers, R. C., L. Scherschun, F. Malick, D. P. Fivenson, and H. W. Lim. Narrowband UVB phototherapy for early-stage mycosis fun-goides. J. Am. Acad. Dermatol. 47: 191-197, 2002.
16. Goldberg, D. J., D. Sarradet, and M. Hussain. 308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol. Surg. 29:596-598; discussion 598-599, 2003.
17. Gundogan, C., B. Greve, I. Hausser, and C. Raulin. [Repigmentation of persistent laser-induced hypopigmentation with an excimer laser following tattoo removal]. Hautarzt 55: 549-552, 2004.
18. Gutierrez-Steil, C., T. Wrone-Smith, X. Sun, J. G. Krueger, T. Coven, and B. J. Nickoloff. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Invest. 101: 33-39, 1998.
19. Hirobe, T., R. Furuya, S. Akiu, O. Ifuku, and M. Fukuda. Keratinocytes control the proliferation and differentiation of cultured epidermal melanocytes from ultraviolet radiation B-induced pigmented spots in the dorsal skin of hairless mice. Pigment Cell Res. 15: 391-399, 2002.
20. Kawalek, A. Z., J. M. Spencer, and R. G. Phelps. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol. Surg. 30(2 pt 1):130-135, 2004.
21. Koster, W., and A. Wiskemann. [Phototherapy with UV-B in vitiligo]. Z. Hautkr. 65:1022-1024, 1029, 1990.
22. Leone, G., P. Iacovelli, A. Paro Vidolin, and M. Picardo. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J. Eur. Acad. Dermatol. Venereol. 17: 531-537, 2003.
23. Lepe, V., B. Moncada, J. P. Castanedo-Cazares, M. B. Torres-Alvares, C. A. Ortiz, and A. B. Torres-Rubalcava. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch. Dermatol. 139: 581-585, 2003.
24. Lindelof, B., B. Sigurgeirsson, E. Tegner, O. Larko, A. Johannesson, B. Berne, B. Ljunggren, T. Andersson, L. Molin, E. Nylander-Lundqvist, and L. Emtestam. PUVA and cancer risk: the Swedish follow-up study. Br. J. Dermatol. 141: 108-112, 1999.
25. Luger, T. A., T. Schwarz, H. Kalden, T. Scholzen, A. Schwarz, and T. Brzoska. Role of epidermal cell-derived alpha-melanocyte stimulating hormone in ultraviolet light mediated local immunosuppression. Ann. N. Y. Acad. Sci. 885: 209-216, 1999.
26. Menchini, G., E. Tsoureli-Nikita, and J. Hercogova. Narrow-band UV-B micro-photo therapy: a new treatment for vitiligo. J. Eur. Acad. Dermatol. Venereol. 17: 171-177, 2003.
27. Miyauchi, H., and T. Horio. Ultraviolet B-induced local immunosuppression of contact hypersensitivity is modulated by ultraviolet irradiation and hapten application. J. Invest. Dermatol. 104: 364-369, 1995.
28. Miyauchi-Hashimoto, H., and T. Horio. Suppressive effect of ultraviolet B radiation on contact sensitization in mice. II. Systemic immunosuppression is modulated by ultraviolet irradiation and hapten application. Photodermatol. Photoimmunol. Photomed. 12: 137-144, 1996.
29. Njoo, M. D., P. I. Spuls, J. D. Bos, W. Westerhof, and P. M. Bossuyt. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch. Dermatol. 134: 1532-1540, 1998.
30. Njoo, M. D., J. D. Bos, and W. Westerhof. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J. Am. Acad. Dermatol. 42(2 pt 1):245-253, 2000.
31. Novak, Z., B. Bonis, E. Baltas, I. Ocsovszki, F. Ignacz, A. Dobozy, and L. Kemeny. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrowband ultraviolet B. J. Photochem. Photobiol. B 67: 32-38, 2002.
32. Ongenae, K., N. Van Geel, and J. M. Naeyaert. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 16: 90-100, 2003.
33. Ostovari, N., T. Passeron, W. Zakaria, E. Fontas, J. C. Larouy, J. F. Blot, J. P. Lacour, and J. P. Ortonne. Treatment of vitiligo by 308nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg. Med. 35: 152-156, 2004.
34. Parrish, J. A.. Phototherapy and photochemotherapy of skin diseases. J. Invest. Dermatol. 77: 167-171, 1981.
35. Parsad, D., R. Saini, and N. Verma. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 197: 167-170, 1998.
36. Passeron, T., N. Ostovari, W. Zakaria, E. Fontas, J. C. Larrouy, J. P. Lacour, and J. P. Ortonne. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch. Dermatol. 140: 1065-1069, 2004.
37. Patel, D. C., A. V. Evans, and J. L. Hawk. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin. Exp. Dermatol. 27: 641-644, 2002.
38. Romero-Graillet, C., E. Aberdam, M. Clement, J. P. Ortonne, and R. Ballotti. Nitric oxide produced by ultraviolet-irradiated ker-atinocytes stimulates melanogenesis. J. Clin. Invest. 99: 635-642, 1997.
39. Schallreuter, K. U., J. M. Wood, K. R. Lemke, and C. Levenig. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 190: 223-229, 1995.
40. Scherschun, L., J. J. Kim, and H. W. Lim. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J. Am. Acad. Dermatol. 44: 999-1003, 2001.
41. Shreedhar, V., T. Giese, V. W. Sung, and S. E. Ullrich. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160: 3783-3789, 1998.
42. Slaper, H., A. A. Schothorst, and J. C. van der Luen. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology 3: 271-283, 1986.
43. Spencer, J. M., R. Nossa, and J. Ajmeri. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J. Am. Acad. Dermatol. 46: 727-731, 2002.
44. Stern, R. S. The risk of melanoma in association with long-term exposure to PUVA. J. Am. Acad. Dermatol. 44: 755-761, 2001.
45. Stern, R. S., K. T. Nichols, and L. H. Vakeva. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N. Engl. J. Med. 336: 1041-1045, 1997.
46. Taneja, A., M. Trehan, and C. R. Taylor. 308-nm excimer laser for the treatment of localized vitiligo. Int. J. Dermatol. 42: 658-662, 2003.
47. Tanghetti, E., and P. R. Gillis. Photometric and clinical assessment of localized UVB phototherapy systems for the high-dosage treatment of stable plaque psoriasis. J. Cosmet. Laser Ther. 5: 101-106, 2003 a.
48. Tanghetti, E. A., and P. R. Gillis. Clinical evaluation of B Clear and Protopic treatment for vitiligo. Lasers Surg. Med. 32(S15): 37, 2003 b.
49. Tjioe, M., T. Smits, P. C. van de Kerkhof, and M. J. Gerritsen. The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp. Dermatol. 12: 729-733, 2003.
50. Toda, K., Y. Miyachi, N. Nesumi, J. Konishi, and S. Imamura. UVB/PUVA-induced suppression of human natural killer activity is reduced by superoxide dismutase and/or interleukin 2 in vitro. J. Invest. Dermatol. 86: 519-522, 1986.
51. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. Epidermal Langer-hans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124: 445-453, 1980.
52. Westerhof, W, and L. Nieuweboer-Krobotova. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch. Dermatol 133: 1525-1528, 1997.
53. Westerhof, W., L. Nieuweboer-Krobotova, P. G. Mulder, and E. J. Glazenburg. Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. Arch. Dermatol. 135: 1061-1066, 1999.
54. Yamawaki, M., S. Futamura, and T. Horio. UVB radiation suppresses the TNF-alpha-induced expression of E-selectin and ICAM-1 on cultured human umbilical vein endothelial cells. J. Dermatol. Sci. 13: 11-17, 1996.
55. Yoshikawa, T., and J. W. Streilein. Tumor necrosis factor-alpha and ultraviolet B light have similar effects on contact hypersensitivity in mice. Reg. Immunol. 3: 139-144, 1990.